 | • レポートコード：MRC2012A3359 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、塞栓粒子の世界市場を広く調査・分析し、今後の市場展望をまとめております。塞栓粒子の種類別市場規模（ミクロスフェア、粒子（PVA粒子・ゲルフォーム粒子・その他）、薬剤溶出性ビーズ（DEB）、放射性塞栓ミクロスフェア（セラスフィア・SIRスフィア・その他））、用途別市場規模（子宮線維塞栓術、前立腺動脈塞栓術（良性前立腺肥大症/BPH治療）、肝腫瘍塞栓術、外傷塞栓術、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sirtex Medical、INterface BIOmaterials B.V.、BTG Medical、Merit Medical、HENGRUI Medical、Cook Medical、Terumo Corporation、Boston Scientific Corporation、Alicon、 ・地域別グローバル市場分析 2015年-2020年 ・塞栓粒子の北米市場（アメリカ、カナダ、メキシコ） ・塞栓粒子のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・塞栓粒子のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・塞栓粒子の南米市場（ブラジル、アルゼンチン） ・塞栓粒子の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ミクロスフェア、粒子（PVA粒子・ゲルフォーム粒子・その他）、薬剤溶出性ビーズ（DEB）、放射性塞栓ミクロスフェア（セラスフィア・SIRスフィア・その他） ・用途別分析：子宮線維塞栓術、前立腺動脈塞栓術（良性前立腺肥大症/BPH治療）、肝腫瘍塞栓術、外傷塞栓術、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Embolization Particle market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Embolization Particle market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 13.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 2557.3 million by 2025, from USD 1567.6 million in 2019.
Market segmentation
Embolization Particle market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Embolization Particle market has been segmented into
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
By Application, Embolization Particle has been segmented into:
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Embolization Particle market presented in the report. This section sheds light on the sales growth of different regional and country-level Embolization Particle markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Embolization Particle market.
The report offers in-depth assessment of the growth and other aspects of the Embolization Particle market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Embolization Particle Market Share Analysis
Embolization Particle competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Embolization Particle sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Embolization Particle sales, revenue and market share for each player covered in this report.
The major players covered in Embolization Particle are:
Sirtex Medical
INterface BIOmaterials B.V.
BTG Medical
Merit Medical
HENGRUI Medical
Cook Medical
Terumo Corporation
Boston Scientific Corporation
Alicon
Among other players domestic and global, Embolization Particle market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Embolization Particle product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Embolization Particle, with price, sales, revenue and global market share of Embolization Particle in 2018 and 2019.
Chapter 3, the Embolization Particle competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Embolization Particle breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Embolization Particle market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Embolization Particle sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Embolization Particle Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Embolization Particle Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Market Analysis by Application
1.3.1 Overview: Global Embolization Particle Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Other
1.4 Overview of Global Embolization Particle Market
1.4.1 Global Embolization Particle Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sirtex Medical
2.1.1 Sirtex Medical Details
2.1.2 Sirtex Medical Major Business
2.1.3 Sirtex Medical SWOT Analysis
2.1.4 Sirtex Medical Product and Services
2.1.5 Sirtex Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 INterface BIOmaterials B.V.
2.2.1 INterface BIOmaterials B.V. Details
2.2.2 INterface BIOmaterials B.V. Major Business
2.2.3 INterface BIOmaterials B.V. SWOT Analysis
2.2.4 INterface BIOmaterials B.V. Product and Services
2.2.5 INterface BIOmaterials B.V. Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BTG Medical
2.3.1 BTG Medical Details
2.3.2 BTG Medical Major Business
2.3.3 BTG Medical SWOT Analysis
2.3.4 BTG Medical Product and Services
2.3.5 BTG Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merit Medical
2.4.1 Merit Medical Details
2.4.2 Merit Medical Major Business
2.4.3 Merit Medical SWOT Analysis
2.4.4 Merit Medical Product and Services
2.4.5 Merit Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 HENGRUI Medical
2.5.1 HENGRUI Medical Details
2.5.2 HENGRUI Medical Major Business
2.5.3 HENGRUI Medical SWOT Analysis
2.5.4 HENGRUI Medical Product and Services
2.5.5 HENGRUI Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cook Medical
2.6.1 Cook Medical Details
2.6.2 Cook Medical Major Business
2.6.3 Cook Medical Product and Services
2.6.4 Cook Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Terumo Corporation
2.7.1 Terumo Corporation Details
2.7.2 Terumo Corporation Major Business
2.7.3 Terumo Corporation Product and Services
2.7.4 Terumo Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Boston Scientific Corporation
2.8.1 Boston Scientific Corporation Details
2.8.2 Boston Scientific Corporation Major Business
2.8.3 Boston Scientific Corporation Product and Services
2.8.4 Boston Scientific Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Alicon
2.9.1 Alicon Details
2.9.2 Alicon Major Business
2.9.3 Alicon Product and Services
2.9.4 Alicon Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Embolization Particle Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Embolization Particle Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Embolization Particle Manufacturer Market Share in 2019
3.3.2 Top 6 Embolization Particle Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Embolization Particle Sales, Revenue and Market Share by Regions
4.1.1 Global Embolization Particle Sales and Market Share by Regions (2015-2020)
4.1.2 Global Embolization Particle Revenue and Market Share by Regions (2015-2020)
4.2 North America Embolization Particle Sales and Growth Rate (2015-2020)
4.3 Europe Embolization Particle Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Embolization Particle Sales and Growth Rate (2015-2020)
4.5 South America Embolization Particle Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Embolization Particle Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Embolization Particle Sales, Revenue and Market Share by Country
5.1.1 North America Embolization Particle Sales and Market Share by Country (2015-2020)
5.1.2 North America Embolization Particle Revenue and Market Share by Country (2015-2020)
5.2 United States Embolization Particle Sales and Growth Rate (2015-2020)
5.3 Canada Embolization Particle Sales and Growth Rate (2015-2020)
5.4 Mexico Embolization Particle Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Embolization Particle Sales, Revenue and Market Share by Country
6.1.1 Europe Embolization Particle Sales and Market Share by Country (2015-2020)
6.1.2 Europe Embolization Particle Revenue and Market Share by Country (2015-2020)
6.2 Germany Embolization Particle Sales and Growth Rate (2015-2020)
6.3 UK Embolization Particle Sales and Growth Rate (2015-2020)
6.4 France Embolization Particle Sales and Growth Rate (2015-2020)
6.5 Russia Embolization Particle Sales and Growth Rate (2015-2020)
6.6 Italy Embolization Particle Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Embolization Particle Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Embolization Particle Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Embolization Particle Revenue and Market Share by Regions (2015-2020)
7.2 China Embolization Particle Sales and Growth Rate (2015-2020)
7.3 Japan Embolization Particle Sales and Growth Rate (2015-2020)
7.4 Korea Embolization Particle Sales and Growth Rate (2015-2020)
7.5 India Embolization Particle Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Embolization Particle Sales and Growth Rate (2015-2020)
7.7 Australia Embolization Particle Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Embolization Particle Sales, Revenue and Market Share by Country
8.1.1 South America Embolization Particle Sales and Market Share by Country (2015-2020)
8.1.2 South America Embolization Particle Revenue and Market Share by Country (2015-2020)
8.2 Brazil Embolization Particle Sales and Growth Rate (2015-2020)
8.3 Argentina Embolization Particle Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Embolization Particle Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Embolization Particle Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Embolization Particle Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Embolization Particle Sales and Growth Rate (2015-2020)
9.3 Turkey Embolization Particle Sales and Growth Rate (2015-2020)
9.4 Egypt Embolization Particle Sales and Growth Rate (2015-2020)
9.5 South Africa Embolization Particle Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Embolization Particle Sales and Market Share by Type (2015-2020)
10.2 Global Embolization Particle Revenue and Market Share by Type (2015-2020)
10.3 Global Embolization Particle Price by Type (2015-2020)
11 Global Embolization Particle Market Segment by Application
11.1 Global Embolization Particle Sales Market Share by Application (2015-2020)
11.2 Global Embolization Particle Revenue Market Share by Application (2015-2020)
11.3 Global Embolization Particle Price by Application (2015-2020)
12 Market Forecast
12.1 Global Embolization Particle Sales, Revenue and Growth Rate (2021-2025)
12.2 Embolization Particle Market Forecast by Regions (2021-2025)
12.2.1 North America Embolization Particle Market Forecast (2021-2025)
12.2.2 Europe Embolization Particle Market Forecast (2021-2025)
12.2.3 Asia-Pacific Embolization Particle Market Forecast (2021-2025)
12.2.4 South America Embolization Particle Market Forecast (2021-2025)
12.2.5 Middle East & Africa Embolization Particle Market Forecast (2021-2025)
12.3 Embolization Particle Market Forecast by Type (2021-2025)
12.3.1 Global Embolization Particle Sales Forecast by Type (2021-2025)
12.3.2 Global Embolization Particle Market Share Forecast by Type (2021-2025)
12.4 Embolization Particle Market Forecast by Application (2021-2025)
12.4.1 Global Embolization Particle Sales Forecast by Application (2021-2025)
12.4.2 Global Embolization Particle Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Embolization Particle Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Embolization Particle by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Embolization Particle Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Embolization Particle Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sirtex Medical Basic Information, Manufacturing Base and Competitors
Table 9. Sirtex Medical Embolization Particle Major Business
Table 10. Sirtex Medical Embolization Particle Total Revenue (USD Million) (2018-2019)
Table 11. Sirtex Medical SWOT Analysis
Table 12. Sirtex Medical Embolization Particle Product and Services
Table 13. Sirtex Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. INterface BIOmaterials B.V. Basic Information, Manufacturing Base and Competitors
Table 15. INterface BIOmaterials B.V. Embolization Particle Major Business
Table 16. INterface BIOmaterials B.V. Embolization Particle Total Revenue (USD Million) (2018-2019)
Table 17. INterface BIOmaterials B.V. SWOT Analysis
Table 18. INterface BIOmaterials B.V. Embolization Particle Product and Services
Table 19. INterface BIOmaterials B.V. Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. BTG Medical Basic Information, Manufacturing Base and Competitors
Table 21. BTG Medical Embolization Particle Major Business
Table 22. BTG Medical Embolization Particle Total Revenue (USD Million) (2018-2019)
Table 23. BTG Medical SWOT Analysis
Table 24. BTG Medical Embolization Particle Product and Services
Table 25. BTG Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Merit Medical Basic Information, Manufacturing Base and Competitors
Table 27. Merit Medical Embolization Particle Major Business
Table 28. Merit Medical Embolization Particle Total Revenue (USD Million) (2018-2019)
Table 29. Merit Medical SWOT Analysis
Table 30. Merit Medical Embolization Particle Product and Services
Table 31. Merit Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. HENGRUI Medical Basic Information, Manufacturing Base and Competitors
Table 33. HENGRUI Medical Embolization Particle Major Business
Table 34. HENGRUI Medical Embolization Particle Total Revenue (USD Million) (2018-2019)
Table 35. HENGRUI Medical SWOT Analysis
Table 36. HENGRUI Medical Embolization Particle Product and Services
Table 37. HENGRUI Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 39. Cook Medical Embolization Particle Major Business
Table 40. Cook Medical Embolization Particle Total Revenue (USD Million) (2018-2019)
Table 41. Cook Medical SWOT Analysis
Table 42. Cook Medical Embolization Particle Product and Services
Table 43. Cook Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 45. Terumo Corporation Embolization Particle Major Business
Table 46. Terumo Corporation Embolization Particle Total Revenue (USD Million) (2018-2019)
Table 47. Terumo Corporation SWOT Analysis
Table 48. Terumo Corporation Embolization Particle Product and Services
Table 49. Terumo Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 51. Boston Scientific Corporation Embolization Particle Major Business
Table 52. Boston Scientific Corporation Embolization Particle Total Revenue (USD Million) (2018-2019)
Table 53. Boston Scientific Corporation SWOT Analysis
Table 54. Boston Scientific Corporation Embolization Particle Product and Services
Table 55. Boston Scientific Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Alicon Basic Information, Manufacturing Base and Competitors
Table 57. Alicon Embolization Particle Major Business
Table 58. Alicon Embolization Particle Total Revenue (USD Million) (2018-2019)
Table 59. Alicon SWOT Analysis
Table 60. Alicon Embolization Particle Product and Services
Table 61. Alicon Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Embolization Particle Sales by Manufacturer (2018-2019) (K Units)
Table 63. Global Embolization Particle Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Embolization Particle Sales by Regions (2015-2020) (K Units)
Table 65. Global Embolization Particle Sales Market Share by Regions (2015-2020)
Table 66. Global Embolization Particle Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Embolization Particle Sales by Countries (2015-2020) (K Units)
Table 68. North America Embolization Particle Sales Market Share by Countries (2015-2020)
Table 69. North America Embolization Particle Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Embolization Particle Revenue Market Share by Countries (2015-2020)
Table 71. Europe Embolization Particle Sales by Countries (2015-2020) (K Units)
Table 72. Europe Embolization Particle Sales Market Share by Countries (2015-2020)
Table 73. Europe Embolization Particle Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Embolization Particle Sales by Regions (2015-2020) (K Units)
Table 75. Asia-Pacific Embolization Particle Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Embolization Particle Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Embolization Particle Sales by Countries (2015-2020) (K Units)
Table 78. South America Embolization Particle Sales Market Share by Countries (2015-2020)
Table 79. South America Embolization Particle Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Embolization Particle Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Embolization Particle Sales by Countries (2015-2020) (K Units)
Table 82. Middle East & Africa Embolization Particle Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Embolization Particle Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Embolization Particle Revenue Market Share by Countries (2015-2020)
Table 85. Global Embolization Particle Sales by Type (2015-2020) (K Units)
Table 86. Global Embolization Particle Sales Share by Type (2015-2020)
Table 87. Global Embolization Particle Revenue by Type (2015-2020) (USD Million)
Table 88. Global Embolization Particle Revenue Share by Type (2015-2020)
Table 89. Global Embolization Particle Sales by Application (2015-2020) (K Units)
Table 90. Global Embolization Particle Sales Share by Application (2015-2020)
Table 91. Global Embolization Particle Sales Forecast by Regions (2021-2025) (K Units)
Table 92. Global Embolization Particle Market Share Forecast by Regions (2021-2025)
Table 93. Global Embolization Particle Sales Forecast by Type (2021-2025) (K Units)
Table 94. Global Embolization Particle Market Share Forecast by Type (2021-2025)
Table 95. Global Embolization Particle Sales Forecast by Application (2021-2025)
Table 96. Global Embolization Particle Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Embolization Particle Picture
Figure 2. Global Sales Market Share of Embolization Particle by Type in 2019
Figure 3. Microspheres Picture
Figure 4. Particles (e.g. PVA Particles, Gelfoam Particles) Picture
Figure 5. Drug-eluting Beads (DEBs) Picture
Figure 6. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Picture
Figure 7. Embolization Particle Sales Market Share by Application in 2019
Figure 8. Uterine Fibroid Embolization Picture
Figure 9. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Picture
Figure 10. Liver Tumor Embolization Picture
Figure 11. Trauma Embolization Picture
Figure 12. Other Picture
Figure 13. Global Embolization Particle Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Embolization Particle Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Embolization Particle Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Embolization Particle Sales Market Share by Manufacturer in 2019
Figure 34. Global Embolization Particle Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Embolization Particle Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Embolization Particle Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Embolization Particle Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Embolization Particle Revenue Market Share by Regions (2015-2020)
Figure 41. Global Embolization Particle Revenue Market Share by Regions in 2018
Figure 42. North America Embolization Particle Sales and Growth Rate (2015-2020)
Figure 43. Europe Embolization Particle Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Embolization Particle Sales and Growth Rate (2015-2020)
Figure 45. South America Embolization Particle Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Embolization Particle Sales and Growth Rate (2015-2020)
Figure 47. North America Embolization Particle Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Embolization Particle Sales Market Share by Countries (2015-2020)
Figure 49. North America Embolization Particle Sales Market Share by Countries in 2018
Figure 50. North America Embolization Particle Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Embolization Particle Revenue Market Share by Countries in 2018
Figure 52. United States Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Embolization Particle Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Embolization Particle Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Embolization Particle Revenue Market Share by Countries in 2019
Figure 58. Germany Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Embolization Particle Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Embolization Particle Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Embolization Particle Revenue Market Share by Regions 2019
Figure 66. China Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Embolization Particle Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Embolization Particle Sales Market Share by Countries in 2019
Figure 73. South America Embolization Particle Revenue Market Share by Countries in 2019
Figure 74. Brazil Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Embolization Particle Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Embolization Particle Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Embolization Particle Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Embolization Particle Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Embolization Particle Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Embolization Particle Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Embolization Particle Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Embolization Particle Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Embolization Particle Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Embolization Particle Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Embolization Particle Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Embolization Particle Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
PVAフォーム塞栓粒子の世界市場（～2026年） Market Analysis and Insights: Global PVA Foam Embolization Particles Market The global PVA Foam Embolization Particles market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global PVA Foam Embolization Particles Scope and Market Si…- 子宮筋腫塞栓術の世界市場（～2026年） Uterine fibroid embolization (UFE) is an effective, non-surgical method used to treat uterine fibroids in the fertile women population. It is performed with the help of uterine fibroid embolization agents, delivered to the tumor by micro-catheters. The embolization agents block the arteries supplyin…
- トリスアクリルゼラチンミクロスフェアの世界市場（～2026年） Market Analysis and Insights: Global Tris-acryl Gelatin Microspheres Market The global Tris-acryl Gelatin Microspheres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tris-acryl Gelatin Microspheres Scope and Market Si…
- 子宮筋腫治療装置の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Uterine Fibroid Treatment Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 粒子特性評価の世界市場（～2026年） Particle characterization is the process of identifying various particles and grouping into categories by particle size, shape, surface properties, Market Analysis and Insights: Global Particle Characterization Market The global Particle Characterization market size is projected to reach US$ XX mill…